The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Linagliptin Market Research Report 2025
Synopsis
Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Thus, linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin in a glucose-dependent manner and decreasing the levels of glucagon in the circulation. CAS no. is 668270-12-0 and molecular formula is C25H28N8O2.
The global Linagliptin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Linagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Linagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Linagliptin include Honor Lab, EstechPharma, Hangzhou Longshine Bio-Tech, Morepen, Suzhou Bichal Biological Technology, Dr. Reddy’s, Shaoxing Hantai Pharmaceutical, Tapi Teva and Wisdom Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Linagliptin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Linagliptin.
Report Scope
The Linagliptin market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Linagliptin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Linagliptin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Honor Lab
EstechPharma
Hangzhou Longshine Bio-Tech
Morepen
Suzhou Bichal Biological Technology
Dr. Reddy’s
Shaoxing Hantai Pharmaceutical
Tapi Teva
Wisdom Pharmaceutical
Shanghai Wonder Pharmaceutical
Beijing Mesochem Technology
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Linagliptin Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Linagliptin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Linagliptin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Linagliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Thus, linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin in a glucose-dependent manner and decreasing the levels of glucagon in the circulation. CAS no. is 668270-12-0 and molecular formula is C25H28N8O2.
The global Linagliptin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Linagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Linagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Linagliptin include Honor Lab, EstechPharma, Hangzhou Longshine Bio-Tech, Morepen, Suzhou Bichal Biological Technology, Dr. Reddy’s, Shaoxing Hantai Pharmaceutical, Tapi Teva and Wisdom Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Linagliptin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Linagliptin.
Report Scope
The Linagliptin market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Linagliptin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Linagliptin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Honor Lab
EstechPharma
Hangzhou Longshine Bio-Tech
Morepen
Suzhou Bichal Biological Technology
Dr. Reddy’s
Shaoxing Hantai Pharmaceutical
Tapi Teva
Wisdom Pharmaceutical
Shanghai Wonder Pharmaceutical
Beijing Mesochem Technology
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Linagliptin Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Linagliptin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Linagliptin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Linagliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Linagliptin Market Overview
1.1 Product Definition
1.2 Linagliptin Segment by Type
1.2.1 Global Linagliptin Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Linagliptin Segment by Application
1.3.1 Global Linagliptin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Linagliptin Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Linagliptin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Linagliptin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Linagliptin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Linagliptin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Linagliptin Production Market Share by Manufacturers (2019-2024)
2.2 Global Linagliptin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Linagliptin, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Linagliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Linagliptin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Linagliptin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Linagliptin, Product Offered and Application
2.8 Global Key Manufacturers of Linagliptin, Date of Enter into This Industry
2.9 Linagliptin Market Competitive Situation and Trends
2.9.1 Linagliptin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Linagliptin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Linagliptin Production by Region
3.1 Global Linagliptin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Linagliptin Production Value by Region (2019-2030)
3.2.1 Global Linagliptin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Linagliptin by Region (2025-2030)
3.3 Global Linagliptin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Linagliptin Production by Region (2019-2030)
3.4.1 Global Linagliptin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Linagliptin by Region (2025-2030)
3.5 Global Linagliptin Market Price Analysis by Region (2019-2024)
3.6 Global Linagliptin Production and Value, Year-over-Year Growth
3.6.1 North America Linagliptin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Linagliptin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Linagliptin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Linagliptin Production Value Estimates and Forecasts (2019-2030)
4 Linagliptin Consumption by Region
4.1 Global Linagliptin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Linagliptin Consumption by Region (2019-2030)
4.2.1 Global Linagliptin Consumption by Region (2019-2024)
4.2.2 Global Linagliptin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Linagliptin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Linagliptin Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Linagliptin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Linagliptin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Linagliptin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Linagliptin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Linagliptin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Linagliptin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Linagliptin Production by Type (2019-2030)
5.1.1 Global Linagliptin Production by Type (2019-2024)
5.1.2 Global Linagliptin Production by Type (2025-2030)
5.1.3 Global Linagliptin Production Market Share by Type (2019-2030)
5.2 Global Linagliptin Production Value by Type (2019-2030)
5.2.1 Global Linagliptin Production Value by Type (2019-2024)
5.2.2 Global Linagliptin Production Value by Type (2025-2030)
5.2.3 Global Linagliptin Production Value Market Share by Type (2019-2030)
5.3 Global Linagliptin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Linagliptin Production by Application (2019-2030)
6.1.1 Global Linagliptin Production by Application (2019-2024)
6.1.2 Global Linagliptin Production by Application (2025-2030)
6.1.3 Global Linagliptin Production Market Share by Application (2019-2030)
6.2 Global Linagliptin Production Value by Application (2019-2030)
6.2.1 Global Linagliptin Production Value by Application (2019-2024)
6.2.2 Global Linagliptin Production Value by Application (2025-2030)
6.2.3 Global Linagliptin Production Value Market Share by Application (2019-2030)
6.3 Global Linagliptin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Honor Lab
7.1.1 Honor Lab Linagliptin Corporation Information
7.1.2 Honor Lab Linagliptin Product Portfolio
7.1.3 Honor Lab Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Honor Lab Main Business and Markets Served
7.1.5 Honor Lab Recent Developments/Updates
7.2 EstechPharma
7.2.1 EstechPharma Linagliptin Corporation Information
7.2.2 EstechPharma Linagliptin Product Portfolio
7.2.3 EstechPharma Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 EstechPharma Main Business and Markets Served
7.2.5 EstechPharma Recent Developments/Updates
7.3 Hangzhou Longshine Bio-Tech
7.3.1 Hangzhou Longshine Bio-Tech Linagliptin Corporation Information
7.3.2 Hangzhou Longshine Bio-Tech Linagliptin Product Portfolio
7.3.3 Hangzhou Longshine Bio-Tech Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.3.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
7.4 Morepen
7.4.1 Morepen Linagliptin Corporation Information
7.4.2 Morepen Linagliptin Product Portfolio
7.4.3 Morepen Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Morepen Main Business and Markets Served
7.4.5 Morepen Recent Developments/Updates
7.5 Suzhou Bichal Biological Technology
7.5.1 Suzhou Bichal Biological Technology Linagliptin Corporation Information
7.5.2 Suzhou Bichal Biological Technology Linagliptin Product Portfolio
7.5.3 Suzhou Bichal Biological Technology Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Suzhou Bichal Biological Technology Main Business and Markets Served
7.5.5 Suzhou Bichal Biological Technology Recent Developments/Updates
7.6 Dr. Reddy’s
7.6.1 Dr. Reddy’s Linagliptin Corporation Information
7.6.2 Dr. Reddy’s Linagliptin Product Portfolio
7.6.3 Dr. Reddy’s Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Dr. Reddy’s Main Business and Markets Served
7.6.5 Dr. Reddy’s Recent Developments/Updates
7.7 Shaoxing Hantai Pharmaceutical
7.7.1 Shaoxing Hantai Pharmaceutical Linagliptin Corporation Information
7.7.2 Shaoxing Hantai Pharmaceutical Linagliptin Product Portfolio
7.7.3 Shaoxing Hantai Pharmaceutical Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Shaoxing Hantai Pharmaceutical Main Business and Markets Served
7.7.5 Shaoxing Hantai Pharmaceutical Recent Developments/Updates
7.8 Tapi Teva
7.8.1 Tapi Teva Linagliptin Corporation Information
7.8.2 Tapi Teva Linagliptin Product Portfolio
7.8.3 Tapi Teva Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Tapi Teva Main Business and Markets Served
7.7.5 Tapi Teva Recent Developments/Updates
7.9 Wisdom Pharmaceutical
7.9.1 Wisdom Pharmaceutical Linagliptin Corporation Information
7.9.2 Wisdom Pharmaceutical Linagliptin Product Portfolio
7.9.3 Wisdom Pharmaceutical Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Wisdom Pharmaceutical Main Business and Markets Served
7.9.5 Wisdom Pharmaceutical Recent Developments/Updates
7.10 Shanghai Wonder Pharmaceutical
7.10.1 Shanghai Wonder Pharmaceutical Linagliptin Corporation Information
7.10.2 Shanghai Wonder Pharmaceutical Linagliptin Product Portfolio
7.10.3 Shanghai Wonder Pharmaceutical Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Shanghai Wonder Pharmaceutical Main Business and Markets Served
7.10.5 Shanghai Wonder Pharmaceutical Recent Developments/Updates
7.11 Beijing Mesochem Technology
7.11.1 Beijing Mesochem Technology Linagliptin Corporation Information
7.11.2 Beijing Mesochem Technology Linagliptin Product Portfolio
7.11.3 Beijing Mesochem Technology Linagliptin Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Beijing Mesochem Technology Main Business and Markets Served
7.11.5 Beijing Mesochem Technology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Linagliptin Industry Chain Analysis
8.2 Linagliptin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Linagliptin Production Mode & Process
8.4 Linagliptin Sales and Marketing
8.4.1 Linagliptin Sales Channels
8.4.2 Linagliptin Distributors
8.5 Linagliptin Customers
9 Linagliptin Market Dynamics
9.1 Linagliptin Industry Trends
9.2 Linagliptin Market Drivers
9.3 Linagliptin Market Challenges
9.4 Linagliptin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
